Research Driven Investing Provides Stocks Research on ImmunoGen and Omeros
Continue ReadingTag: research-driven-investing
U.S. Food and Drug Administration Approved 30% More Drugs in 2012
Research Driven Investing Provides Stocks Research on Athersys and Rexahn Pharmaceuticals
Continue ReadingFDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High
Research Driven Investing Provides Stocks Research on AEterna Zentaris and Oncolytics Biotech
Continue ReadingNevada Casinos Revenues Total $10.86 Billion in 2012 — Third Consecutive Annual Increase
RDInvesting Provides Stock Research on Caesars Entertainment and MGM Resorts International
Continue ReadingBiotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High
Research Driven Investing Provides Stocks Research on Alnylam and Arena
Continue ReadingLas Vegas Sands and Wynn Resorts Rise as Gambling Revenues in Nevada Surge 10 Percent in December
RDInvesting Provides Stock Research on Las Vegas Sands and Wynn Resorts
Continue ReadingU.S. Food and Drug Administration Approved 30% More Drugs in 2012
Research Driven Investing Provides Stocks Research on Optimer Pharmaceuticals and Santarus
Continue ReadingSharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success
Research Driven Investing Provides Stocks Research on Amicus Therapeutics and Novavax
Continue ReadingTotal Health Care Spending Projected Grow 70% by 2021
Research Driven Investing Provides Stocks Research on Mylan and Teva Pharmaceutical
Continue ReadingCenters for Medicare and Medicaid Services Projects Health Care Spending to Grow From $2.8 Trillion to $4.8 Trillion by 2021
Research Driven Investing Provides Stocks Research on CIGNA and Express Scripts
Continue Reading